Mirum Pharmaceuticals, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| May 2018 | — | $0 | — |
| Jun 2018 | — | $-10.0K | — |
| Sep 2018 | — | $-76.0K | — |
| Dec 2018 | — | $-17.3M | $52.0M |
| Mar 2019 | — | $-23.1M | — |
| Jun 2019 | — | $-34.9M | $41.8M |
| Sep 2019 | — | $146.2M | $30.8M |
| Dec 2019 | — | $130.3M | $12.0M |
| Mar 2020 | — | $156.1M | $72.0M |
| Jun 2020 | — | $136.2M | $83.0M |
| Sep 2020 | — | $120.3M | $48.8M |
| Dec 2020 | — | $172.1M | $142.1M |
| Mar 2021 | — | $133.9M | $90.7M |
| Jun 2021 | — | $95.7M | $91.9M |
| Sep 2021 | — | $56.4M | $55.8M |
| Dec 2021 | — | $120.2M | $31.3M |
| Mar 2022 | — | $108.9M | $46.3M |
| Jun 2022 | — | $110.7M | $55.3M |
| Sep 2022 | — | $169.3M | $35.8M |
| Dec 2022 | — | $142.0M | $28.0M |
| Mar 2023 | — | $141.2M | $49.4M |
| Jun 2023 | — | $78.6M | $297.2M |
| Sep 2023 | — | $269.1M | $303.1M |
| Dec 2023 | — | $248.7M | $286.3M |
| Mar 2024 | — | $234.6M | $302.8M |
| Jun 2024 | — | $229.0M | $233.2M |
| Sep 2024 | — | $232.0M | $223.0M |
| Dec 2024 | — | $225.6M | $222.5M |
| Mar 2025 | — | $233.3M | $211.8M |
| Jun 2025 | — | $255.2M | $228.1M |
| Sep 2025 | — | $292.0M | $282.0M |
| Dec 2025 | — | $314.7M | $296.7M |
| Mar 2026 | — | $242.5M | $324.9M |
| Jun 2026 | — | $-10.4M | $330.7M |